does glp 1 cause cancer Long-term risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial GLP-1 Receptor Agonists as Treatments

Currently, the use of GLP-1 RAs in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) is contraindicated

[DOI] [PubMed] [Google Scholar] 66.Kim S-J, Winter K, Nian C, et al

So researchers looked at the medical records of more than 3,000 people with hormone receptor-positive DCIS on hormonal therapy and GLP-1s, as well as an equal number of people with hormone receptor-positive DCIS who were not taking GLP-1s

iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss owenhaskins Jun 27, 2024 3 min read iHerb has launched three new supplements specifically designed to support individuals using semaglutide (GLP-1 agonists) by addressing common side effects such as digestive issues including nausea and pain, loss of muscle mass and skin elasticity, and changing blood sugar levels

Tirzepatide wins on efficacy among currently available options

It is important that you fully read the information given to you by your doctor and seek answers to any questions or concerns